Cerebral Vasoregulation in Diabetes 1.0.0
(9,047 bytes)
Visit | Physionet Directory | Directory | Protocol | Filename | Format | Channels | Sampling rate | Label | description | units | Calibration | Equipment | Device output sampling rate | Experiment | |||||
Day 1 | Not Uploaded | Screening | ICF | ||||||||||||||||
PCP permission | |||||||||||||||||||
Blood draw | |||||||||||||||||||
Retinal imaging | |||||||||||||||||||
Day 1 | Not Uploaded | TCD | TCD window | ||||||||||||||||
Day 1 | Data/Labview/ Head-upTilt_ Day1 | Head-up tilt test | Deep breathing at 0.1Hz | ||||||||||||||||
Valsalva maneuver | |||||||||||||||||||
5-minutes head-up tilt test | S#####DA.dat | 1 | marker | ||||||||||||||||
2 | ECG | ECG | |||||||||||||||||
3 | ABP | finger blood pressure waveform | mmHg | *100 | Finapress | 100 HZ | |||||||||||||
4 | Mcar | right middle cerebral artery flow velocity waveform | cm/s | Multi | empty channels not recorded | ||||||||||||||
5 | Mcal | left middle cerebral artery flow velocity waveform | cm/s | MultiDop X4, DWL Neuroscan Inc, Sterling, VA | 50 Hz | empty channels not recorded | |||||||||||||
6 | Radi | radial artery flow velocity waveform | c,/s | empty channels not recorded | |||||||||||||||
7 | Thermst | respiration with nasal thermistor | relative | thermisor | |||||||||||||||
8 | Flow rate | respiration flow rate | Capnomac Ultima | ||||||||||||||||
9 | O2 | end tidal O2 | mmHg | *9.09 | Capnomac Ultima | ||||||||||||||
10 | CO2 | end tidal CO2 | mmHg | *7.74 | Capnomac Ultima | ||||||||||||||
Day 1 | Not Uploaded | Portapress | Beat-to-beat BP | Portapress resting continuous beat-to-beat BP during head-up tilt (day 1) recording | |||||||||||||||
S####D_Portapress.dat | |||||||||||||||||||
Note: This was recorded during Head-up tilt test. Not all the subjects had a recording. | |||||||||||||||||||
Note: During recording the machine did not work proprerly, so files which are labeled as Beat1, Beat2, Beat 3 and Beat4. It means those files are from the same subject. | |||||||||||||||||||
Day 1 | Data/Pedar | Pedar | 12 minute Walking test | Walk test 1&2 ( walk1 around 11 am and walk 2 in the afternoon, normal hallway walking for 12 min recorded with EMG channels using ME6000) and foot pressure distribution using pedar mobile, some subjects also have Portapress beat-to-beat blood pressure) | ME6000 | ||||||||||||||
Walking test- foot pressure distribution and walking characteristics using Pedar Mobile | |||||||||||||||||||
S####DA.ASC_Pedar | DAT | ||||||||||||||||||
S####DA.ASC_Pedar | HEA | ||||||||||||||||||
16 | |||||||||||||||||||
header: filename, left insole #, right insole #, mean step left, mean step right, min and max step, total time (s econds), distance ( meters),velocity (m/s) | |||||||||||||||||||
1 | step_no | ||||||||||||||||||
2 | foot | ||||||||||||||||||
3 | max. force[N] | ||||||||||||||||||
4 | mean force[N] | ||||||||||||||||||
5 | max pressure [N/cm²] | ||||||||||||||||||
6 | start | ||||||||||||||||||
7 | start in % of total time | ||||||||||||||||||
8 | stride | ||||||||||||||||||
9 | step | ||||||||||||||||||
10 | stance | ||||||||||||||||||
11 | stance in % of stride | ||||||||||||||||||
12 | swing | ||||||||||||||||||
13 | swing in % | ||||||||||||||||||
14 | init double in % | ||||||||||||||||||
15 | single limb support % | ||||||||||||||||||
16 | terminate double % | ||||||||||||||||||
Day 2 | Data/Labview/ Head-upTilt_ Day2 | Labview | Head up tilt | Vasoreactivity, Valsalva maneuver, Head up tilt | |||||||||||||||
TCD | with TCD | ||||||||||||||||||
Valsalva manuever | |||||||||||||||||||
5 min supine baseline | S####DB.dat | Labview | 10 | 500 Hz | V | ||||||||||||||
3 min hyperventilation | |||||||||||||||||||
3 min CO2 rebreathing | 1 | marker | baseline | Valsalva maneuver | hyperventilation | Co2 rebreathing | head-up tilt | baseline | |||||||||||
5 min supine rest | 2 | ECG | ECG | ||||||||||||||||
Head up tilt 10 min | 3 | ABP | finger blood pressure waveform | mmHg | *100 | Finapress | 100 HZ | ||||||||||||
4 | Mcar | right middle cerebral artery flow velocity waveform | cm/s | Multi | |||||||||||||||
5 | Mcal | left middle cerebral artery flow velocity waveform | cm/s | MultiDop X4, DWL Neuroscan Inc, Sterling, VA; | 50 Hz | ||||||||||||||
6 | Radi | radial artery flow velocity waveform | c,/s | ||||||||||||||||
7 | Thermst | respiration with nasal thermistor | relative | thermisor | |||||||||||||||
8 | Flow rate | respiration flow rate | Capnomac Ultima | ||||||||||||||||
9 | O2 | end tidal O2 | mmHg | *9.09 | Capnomac Ultima | ||||||||||||||
10 | CO2 | end tidal CO2 | mmHg | *7.74 | Capnomac Ultima | ||||||||||||||
Day 2 | Data/Labview/Sit-To-Stand | labview-sit-to-stand | Sit-to stand with eyes open and closed | Sit-to-stand Test | |||||||||||||||
5 min sitting with eyes open on balance platform with simultaneous cardiovascular, TCD | |||||||||||||||||||
5 min standing with eyes open on balance platform with simultaneous cardiovascular, TCD and balance measures | |||||||||||||||||||
5 min sitting with eyes closed on balance platform with simultaneous cardiovascular, TCD | |||||||||||||||||||
5 min standing with eyes closed on balance platform with simultaneous cardiovascular, TCD and balance measures | |||||||||||||||||||
S####DC.dat | Labview | 15 | 1000 Hz | V | |||||||||||||||
1 | marker | sitting 5min | standing eyes open 3min | sitting | standing eyes closed | ||||||||||||||
2 | ECG | ECG | |||||||||||||||||
3 | ABP | finger blood pressure waveform | mmHg | *100 | Finapress | ||||||||||||||
4 | Mcar | right middle cerebral artery flow velocity waveform | cm/s | Multi | |||||||||||||||
5 | Mcal | left middle cerebral artery flow velocity waveform | cm/s | MultiDop X4, DWL Neuroscan Inc, Sterling, VA; | |||||||||||||||
6 | Radi | radial artery flow velocity waveform | cm/s | ||||||||||||||||
7 | Thermst | respiration with nasal thermistor | relative | thermisor | |||||||||||||||
8 | Flow rate | respiration flow rate | ml/s | Capnomac Ultima | |||||||||||||||
9 | O2 | end tidal O2 | mmHg | *9.09 | Capnomac Ultima | ||||||||||||||
10 | CO2 | end tidal CO2 | mmHg | *7.74 | Capnomac Ultima | ||||||||||||||
11 | fx | sway trajectory in mediolateral direction | mm | Kistler Force plate, Amherst MA | |||||||||||||||
12 | fy | sway trajectory in anteroposterior direction | mm | ||||||||||||||||
13 | fz | sway trajectory in vertical direction | mm | ||||||||||||||||
14 | px | center of pressure x component | mm | ||||||||||||||||
15 | py | center of pressure x component | mm | ||||||||||||||||
S#####DC.ch1-10.dat | Labview | 10 | 1000 Hz | ||||||||||||||||
1 | marker | ||||||||||||||||||
2 | ECG | ECG | |||||||||||||||||
3 | ABP | finger blood pressure waveform | mmHg | *100 | Finapress | ||||||||||||||
4 | Mcar | right middle cerebral artery flow velocity waveform | cm/s | Multi | |||||||||||||||
5 | Mcal | left middle cerebral artery flow velocity waveform | cm/s | MultiDop X4, DWL Neuroscan Inc, Sterling, VA; | |||||||||||||||
6 | Radi | radial artery flow velocity waveform | cm/s | ||||||||||||||||
7 | Thermst | respiration with nasal thermistor | relative | thermisor | |||||||||||||||
8 | Flow rate | respiration flow rate | ml/s | Capnomac Ultima | |||||||||||||||
9 | O2 | end tidal O2 | mmHg | *9.09 | Capnomac Ultima | ||||||||||||||
10 | CO2 | end tidal CO2 | mmHg | *7.74 | Capnomac Ultima | ||||||||||||||
Day 3 | Not uploaded | 3T MRI | Anatomical MRI | MRI- anatomical, CBF regional perfusiona dn paerfusion in vascular territories; CO2 vasoreactivity to hyperventilation and C02 rebreathing | |||||||||||||||
Perfusion MRI | 3Tesla GE Signa Vhi or Excite scanner and phase arrays head coil ( GE Medical Systmes, Milwaukee, WI) | ||||||||||||||||||
MP-RAGE | MP-RAGE) (repetition | ml or % of total brain volume | |||||||||||||||||
time [TR]/echo time [TE]/inversion time [TI] 7.8/3.1/600 | |||||||||||||||||||
msec, 3.0 mm slice thickness, 52 slices, bandwidth 122 Hz | |||||||||||||||||||
per pixel, flip angle 10°, 24 cm 24 cm field of view [FOV], | |||||||||||||||||||
256 192 matrix size) | |||||||||||||||||||
FLAIR | fluid-attenuated inversion recovery | ||||||||||||||||||
(FLAIR) (TR/TE/TI 11,000/161/2,250 msec, 5 mm slice | |||||||||||||||||||
thickness, 30 slices, bandwidth 122 Hz per pixel, flip angle | |||||||||||||||||||
90°, 24 cm 24 cm FOV, 256 160 matrix size), | |||||||||||||||||||
DWI | diffusion-weighted image (b value of 1,000 seconds/ | ||||||||||||||||||
mm2, TR/TE 10,000/86.6 msec, 5 mm slice thickness, bandwidth | |||||||||||||||||||
250 kHz, 128 128 matrix size | |||||||||||||||||||
CASL | CBF | three-dimensional stack of | mL · 100 g1 · min1 | ||||||||||||||||
interleaved spirals fast spin echo sequence (TR/TE 6,000/ | |||||||||||||||||||
23.8 msec, echo train length 66, with a 18 18 cm FOV, in | |||||||||||||||||||
the coronal plane and 64 slices with thickness 3.8 mm, eight | |||||||||||||||||||
see Zhao et al. Neurology 2009 ;72:643-649 for procecessing details | spiral interleaves, two averages and a bandwidth62.5 kHz). | ||||||||||||||||||
Transcranial Doppler | |||||||||||||||||||
Day 4 | Not uploaded | Neurological Examination | The physician assessed for the presence of neuropathy using the neuropathy checklist. |